Global Vascular Grafts and Peripheral Stents Market Segmentation, By Product Type (Vascular Graft and Peripheral Stent), Vascular Graft Raw Material Source (Synthetic, Biosynthetic, and Biological), Vascular Graft Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, and Hemodialysis Access), Peripheral Stent Artery Type (Carotid Artery, Fem-Pop Artery, Iliac Artery, and Infrapop Artery), Vascular Graft Application (Coronary Artery Disease, Vascular Occlusion, Aneurysm, Renal Failure, and Others), End Users (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Specialty Clinics, and Others) – Industry Trends and Forecast to 2031
Vascular Grafts and Peripheral Stents Market Analysis
The vascular grafts and peripheral stents market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, advancements in minimally invasive techniques, and a rising aging population. Dominated by synthetic and biosynthetic materials, the market benefits from enhanced biocompatibility and durability. Recent developments include innovative drug-eluting stents that significantly reduce the risk of restenosis and improve patient outcomes. In addition, the emergence of biodegradable stents is promising fewer long-term complications, attracting attention from healthcare providers. As companies invest in R&D to develop next-generation products, the market is poised for continued expansion, supported by rising healthcare expenditures and improved access to medical services globally, reflecting a positive outlook for future innovations and treatments.
Vascular Grafts and Peripheral Stents Market Size
The global vascular grafts and peripheral stents market size was valued at USD 3.72 billion in 2023 and is projected to reach USD 5.93 billion by 2031, with a CAGR of 6.00% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Vascular Grafts and Peripheral Stents Market Trends
“Increasing Adoption of Drug-Eluting Technologies”
Vascular grafts and peripheral stents market is the growing adoption of drug-eluting technologies, which are revolutionizing treatment for patients with vascular diseases. These technologies involve coating stents with medications that help prevent restenosis, or the re-narrowing of blood vessels, after a procedure. By delivering drugs directly to the affected area, drug-eluting stents significantly improve patient outcomes by reducing the risk of artery blockage and the need for repeat interventions. As awareness of peripheral artery disease (PAD) continues to grow, healthcare providers are increasingly opting for these advanced stents, recognizing their potential to deliver more effective and long-lasting results. Additionally, the broader trend towards minimally invasive procedures is fueling demand for drug-eluting stents, as these devices offer quicker recovery times, lower complication rates, and improved overall patient experience. As a result, the integration of drug delivery systems into vascular interventions is driving innovation and transforming the landscape of the market.
Report Scope and Vascular Grafts and Peripheral Stents Market Segmentation
|
Attributes
|
Vascular Grafts and Peripheral Stents Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), AstraZeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Science (France), Eisai Co., Ltd. (Japan), Genentech, Inc. (U.S.), and Merck & Co., Inc. (U.S.)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Vascular Grafts and Peripheral Stents Market Definition
Vascular grafts and peripheral stents are essential medical devices used to treat various vascular conditions. Vascular grafts serve to replace or bypass damaged blood vessels, enhancing blood flow in patients with vascular diseases or aneurysms. These grafts can be constructed from synthetic, biosynthetic, or biological materials, providing options that cater to specific medical needs. Peripheral stents, on the other hand, are mesh-like tubes inserted into narrowed or blocked arteries, particularly in the limbs, to maintain vessel patency and restore blood circulation. Both devices significantly improve patient outcomes by facilitating better blood flow and reducing the risk of complications associated with vascular diseases.
Vascular Grafts and Peripheral Stents Market Dynamics
Drivers
- Rising Incidence of Cardiovascular Disease
The rising incidence of conditions such as coronary artery disease, peripheral artery disease, and aneurysms is a primary driver for the demand for vascular grafts and stents. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year, which underscores the urgent need for effective treatment options. As these conditions become more prevalent due to factors like sedentary lifestyles, obesity, and aging populations, healthcare providers increasingly rely on vascular interventions to manage and treat these ailments. This growing patient population necessitates the use of vascular grafts and stents to restore blood flow and prevent serious complications, thereby driving innovation and investment in this critical sector of cardiovascular healthcare.
- Minimally Invasive Surgical Techniques
The shift towards minimally invasive surgical techniques has revolutionized the approach to treating vascular conditions, significantly improving patient outcomes. These techniques, which include procedures like endovascular stent placement and laparoscopic grafting, allow for smaller incisions and less trauma to the body. As a result, patients experience shorter recovery times, reduced pain, and fewer complications compared to traditional open surgeries. This efficiency encourages healthcare providers to adopt these methods more frequently, leading to an increase in the utilization of vascular grafts and stents. In addition, the enhanced precision of minimally invasive procedures can lead to better long-term results, further driving demand for these advanced medical devices. Overall, this trend benefits patients and contributes to a more efficient healthcare system.
Opportunities
- Enhancing Treatment Efficacy and Safety
Innovations in the vascular grafts and peripheral stents market present significant growth opportunities by enhancing treatment efficacy and safety. Bioresorbable stents, which gradually dissolve in the body, reduce long-term complications associated with permanent implants, making them appealing for both patients and healthcare providers. Drug-eluting stents, designed to release medication that prevents restenosis, further improve patient outcomes by minimizing the risk of artery narrowing after procedures. In addition, advancements in graft materials, particularly biocompatible polymers, enhance biocompatibility and reduce adverse reactions. These innovations not only revolutionize treatment protocols but also create a competitive edge for manufacturers, opening new revenue streams and increasing market demand as healthcare providers seek safer, more effective solutions for vascular diseases.
- Improvement of Healthcare Infrastructure in Developing Regions
The improvement of healthcare infrastructure in developing regions presents a significant market opportunity for companies in the vascular grafts and peripheral stents sector. As these areas enhance their medical facilities and expand healthcare services, access to vascular treatments is increasing. This trend is crucial given the rising prevalence of vascular diseases such as peripheral artery disease and coronary artery disease in these populations. Companies can capitalize on this opportunity by introducing innovative, affordable products tailored to local needs, collaborating with healthcare providers, and engaging in public health initiatives. By addressing the unique challenges and demands of these markets, businesses can not only boost their sales but also play a vital role in improving health outcomes, creating opportunities for long-term growth and sustainability.
Restraints/Challenges
- High Costs of Development
The significant investment required for research, development, and clinical trials represents a considerable barrier in the vascular grafts and peripheral stents market, especially for smaller companies. These organizations often face financial constraints that limit their ability to undertake the extensive resources needed for innovative product development. The process of conducting clinical trials is not only lengthy but also costly, requiring substantial funding for materials, personnel, and compliance with regulatory standards. In addition, the risk of failure during trials can deter potential investors, further restricting funding opportunities. As a result, smaller companies may find it challenging to compete with larger players, leading to slower innovation and reduced diversity in product offerings within the market.
- Complex Regulatory Requirements
The lengthy and complex regulatory approval processes are a significant restraint in the vascular grafts and peripheral stents market, often delaying the introduction of new products and limiting market entry for innovative solutions. Companies must navigate intricate frameworks set by regulatory bodies, which require extensive documentation, clinical trial data, and compliance with stringent safety and efficacy standards. This protracted process can extend over several years, allowing competitors to launch similar products and saturate the market, thereby diminishing the potential impact of new innovations. In addition, the uncertainty surrounding approval timelines can deter investment, particularly for smaller firms that may lack the financial resources to endure prolonged development phases. As a result, these regulatory hurdles stifle innovation and restrict the availability of advanced solutions for patients and healthcare providers.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Vascular Grafts and Peripheral Stents Market Scope
The market is segmented on the basis of product type, vascular graft raw material source, vascular graft indication, peripheral stent artery type, vascular graft application, and end users.The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Vascular Graft
- Endovascular Stent Graft
- Peripheral Vascular Graft
- Hemodialysis Access Graft
- Bypass Graft
- Others
- Peripheral Stent
Vascular Graft Raw Material Source
- Synthetic
- Polytetrafluethylene (PTFE)
- Polyurethane (PU)
- Dacron
- Others
- Biological
- Bovine Vein
- Saphenous Vein
- Others
- Biosynthetic
- Ovine Collagen with Polyester
- Others
Vascular Graft Indication
- Endovascular Aneurysm Repair
- Peripheral Vascular Repair
- Hemodialysis Access
Peripheral Stent Artery Type
- Carotid Artery
- Fem-Pop Artery
- Iliac Artery
- Infrapop Artery
Vascular Graft Application
- Coronary Artery Disease
- Vascular Occlusion
- Aneurysm
- Renal Failure
- Others
End Users
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
- Specialty Clinics
- Others
Vascular Grafts and Peripheral Stents Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, product type, raw material source, indication, artery type, application, and end users as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the global vascular grafts and peripheral stents market in both market share and revenue, and this trend is expected to continue from 2024 to 2031. The region benefits from significant investments in research and development, bolstered by government initiatives aimed at enhancing healthcare. In addition, improvements in healthcare infrastructure across various countries further support the region’s dominant position in the market.
Asia-Pacific region is anticipated to record the highest growth rate in the global vascular grafts and peripheral stents market from 2024 to 2031 This growth is driven by rising government investments in the healthcare sector, aimed at improving access and quality of care. In addition, ongoing technological advancements and supportive government initiatives are further propelling the region’s market expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Vascular Grafts and Peripheral Stents Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Vascular Grafts and Peripheral Stents Market Leaders Operating in the Market Are:
- GSK plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- AstraZeneca (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sanofi (U.S.)
- Amgen Inc. (U.S.)
- DAIICHI SANKYO COMPANY, LIMITED. (Japan)
- AB Science (France)
- Eisai Co., Ltd. (Japan)
- Genentech, Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
Latest Developments in Vascular Grafts and Peripheral Stents Market
- In September 2023 Recently, the Castor Branched Aortic Stent-Graft and Delivery System (Castor Branched Stent-Graft), the Minos Abdominal Aortic Stent-Graft and Delivery System (Minos Stent-Graft), and the Hercules Thoracic Stent Graft System with Low Profile Delivery System (Hercules LP Stent Graft) have received registration approval from the Thailand Food and Drug Administration (TFDA). These three products represent Endovastec's key offerings for endovascular interventions targeting thoracic and abdominal aortic diseases
- In Aug 2022 W. L. Gore & Associates, Inc. (Gore), a global leader in material science committed to transforming industries and enhancing lives, has announced the acquisition of InnAVasc Medical, Inc., a privately-held medical technology firm dedicated to improving care for patients with end-stage renal disease who rely on graft circuits for dialysis treatment
SKU-